JUN 18, 2019 8:19 AM PDT

Scientists Identify Which Gut Bacteria Interfere With Parkinson's Treatment

WRITTEN BY: Tiffany Dazet

A new study from a team of Harvard scientists discovered one of the first distinct examples of how gut bacteria can interfere with a drug’s pathway through the body. Out of the trillions of possible culprits, the team was able to identify which bacteria degrade the drug and how to stop the interference.

The study, recently published in Science, focused on levodopa (L-dopa), which has been the primary treatment for Parkinson’s disease for the past 50 years. L-dopa relieves Parkinson’s symptoms by delivering dopamine to the brain. However, it is estimated that only about one to five percent of the drug actually reaches the brain.

When the L-dopa metabolizes outside the brain, the resulting dopamine causes side effects, including severe gastrointestinal distress and cardiac arrhythmias. In addition, patients are often given higher doses of the drug to combat symptoms, possibly intensifying these side effects. 

To increase the efficacy of L-dopa, a new drug to block the L-dopa metabolism—carbidopa—was introduced, and the combination of the pills seemed to help Parkinson’s patients. Although this solution exists, the research team wanted to dig deeper and discover the unexplained drug metabolism and reasons for efficacy variance between patients.

Using data from the Human Microbiome Project, the team was able to identify specific enzymes produced by two different bacterial species that work together to digest L-dopa in the human gut. Enterococcus faecalis absorbs L-dopa and converts it to dopamine while Eggerthella lenta converts dopamine into meta-tyramine, which may be responsible for L-dopa’s side effects.

In a statement from Harvard’s Department of Chemistry and Chemical Biology, lead author Professor Emily Balskus stated that “all of this suggests that gut microbes may contribute to the dramatic variability that is observed in side effects and efficacy between different patients taking L-dopa.”

Using mice, the research team also identified a small molecule—alpha-fluoromethyltyrosine (AFMT)—that could block this particular metabolic pathway, thereby increasing the efficacy of L-dopa in Parkinson’s patients. Although this may result in Parkinson’s patients requiring a third drug for treatment, Balskus stated that their discovery “opens up the door to the possibility of developing a new class of therapeutics to improve patient response to L-dopa—that would be drugs targeting gut microbe metabolism in addition to targeting host metabolism.”

Sources: Harvard, Science Magazine, New Scientist

About the Author
  • Tiffany grew up in Southern California, where she attended San Diego State University. She graduated with a degree in Biology with a marine emphasis, thanks to her love of the ocean and wildlife. With 13 years of science writing under her belt, she now works as a freelance writer in the Pacific Northwest.
You May Also Like
OCT 03, 2021
Microbiology
Using a New Approach to Assess Aging & the Microbiome
OCT 03, 2021
Using a New Approach to Assess Aging & the Microbiome
Metagenomic tools enable scientists to easily sequence all of the DNA in any sample, like soil, or feces. The results ca ...
OCT 05, 2021
Genetics & Genomics
Genetic Mutations May Not be Related to the Aging Process
OCT 05, 2021
Genetic Mutations May Not be Related to the Aging Process
As our body ages, cells have to divide to replenish those that become worn out or damaged. Most cells also carry the gen ...
OCT 13, 2021
Earth & The Environment
Fighting Back Against Harmful Algal Blooms
OCT 13, 2021
Fighting Back Against Harmful Algal Blooms
Harmful algal blooms, or HABs, are a common summertime nuisance for people that live near fresh or saltwater all over th ...
OCT 16, 2021
Cell & Molecular Biology
Microtubules Found to Act as Mechanosensors
OCT 16, 2021
Microtubules Found to Act as Mechanosensors
As organisms grow, live, and move through the world, they're subjected to an array of internal and external forces. Biol ...
OCT 18, 2021
Health & Medicine
Emerging Research on Delta 8 THC
OCT 18, 2021
Emerging Research on Delta 8 THC
Delta-8-tetrahydrocannabinol is a cannabinoid derived from the hemp plant. It is one of the more prominent compounds, bu ...
OCT 19, 2021
Cell & Molecular Biology
Mouse Fathers Passed Immunity Onto Offpsring After Infection
OCT 19, 2021
Mouse Fathers Passed Immunity Onto Offpsring After Infection
Parents pass their genes on to their children. But they can pass down other things too with epigenetic marks, chemical t ...
Loading Comments...